ஏற்பி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஏற்பி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஏற்பி Today - Breaking & Trending Today

Ozanimod Wins FDA Approval in Ulcerative Colitis

S1P receptor modulator indicated for moderate to severe disease ....

United States , Zaina Hamza , Ozanimod Zeposia , Bristol Myers Squibb , True North , Medpage Today , Ulcerative Colitis , Macular Edema , ஒன்றுபட்டது மாநிலங்களில் , பிரிஸ்டல் மைஸ் ஸ்க்விப்ப் , மாகுலர் எடிமா ,

Welcome To IANS Live - SCIENCE - Australian scientists develop new drugs to fight Covid-19

The two early intervention drugs target how human cells respond to the SARS-CoV-2 virus, instead of the virus itself, according to the findings published in the journal Nature Cell Discovery.The ....

New South Wales , Dakul Seth , Berghofer Medical Research Institute , News Service , India Private , Medical Research Institute , All Rights , புதியது தெற்கு வேல்ஸ் , பெர்கோஃபர் மருத்துவ ஆராய்ச்சி நிறுவனம் , செய்தி சேவை , இந்தியா ப்ரைவேட் , மருத்துவ ஆராய்ச்சி நிறுவனம் , அனைத்தும் உரிமைகள் ,

Welcome To IANS Live - INTERNATIONAL - Australian scientists develop new drugs to fight Covid-19

The two early intervention drugs target how human cells respond to the SARS-CoV-2 virus, instead of the virus itself, according to the findings published in the journal Nature Cell Discovery.The ....

New South Wales , Dakul Seth , Berghofer Medical Research Institute , News Service , India Private , Medical Research Institute , All Rights , புதியது தெற்கு வேல்ஸ் , பெர்கோஃபர் மருத்துவ ஆராய்ச்சி நிறுவனம் , செய்தி சேவை , இந்தியா ப்ரைவேட் , மருத்துவ ஆராய்ச்சி நிறுவனம் , அனைத்தும் உரிமைகள் ,

Welcome To IANS Live - LatestNews - Gene linked to balding may up Covid severity in men

Photo Credit: IANS
IANSLive
New York, May 9 (IANS) Men with a common form of hormone-sensitive hair loss are more prone to being hospitalised and at risk for ICU admission due to Covid-19, researchers have found.
To get full access of the story, click here to subscribe to IANS News Service
© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.
For news, views and gossips, follow IANS at Twitter.
Update: 09-May-2021 ....

New York , United States , News Service , India Private , All Rights , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , செய்தி சேவை , இந்தியா ப்ரைவேட் , அனைத்தும் உரிமைகள் ,

Research may lead to a significant breakthrough in the battle against deadly brain tumors

Research may lead to a significant breakthrough in the battle against deadly brain tumors
Groundbreaking research from Tel Aviv University may lead to a significant breakthrough in the battle against deadly brain cancer. To begin with, the researchers identified a failure in the brain s immune system, leading to the amplification of cell division and spread of Glioblastoma cancer cells. The failure results partially from the secretion of a protein called P-Selectin (SELP), which, when bound to its receptor on the brain immune cells, alters their function so that instead of inhibiting the spread of cancer cells, they do the opposite, enabling them to proliferate and penetrate brain tissues. ....

United States , Eilam Yeini , Ronit Satchi Fainaro , Asaf Madi , Emily Henderson , Johns Hopkins University , Israel Cancer Research Fund , Nature Communications , Lieber Institute , Head Of The Cancer Research , Israel Science Foundation , Nanomedicine Laboratory , Israel Cancer Association , Morris Kahn Foundation , Cancer Biology Research Center , Tel Aviv Sourasky Medical Center Ichilov , Kadar Family Awards For Outstanding Research , Tel Aviv University Sackler Faculty Of Medicine , European Research Council , Tel Aviv University , Cancer Research , Sackler Faculty , Tel Aviv Sourasky Medical Center , Kadar Family Awards , Outstanding Research , Immune System ,